000 01181 a2200349 4500
005 20250515002514.0
264 0 _c20060206
008 200602s 0 0 eng d
022 _a0307-6938
024 7 _a10.1111/j.1365-2230.2005.01882.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPeramiquel, L
245 0 0 _aOnset of flexural psoriasis during infliximab treatment for Crohn's disease.
_h[electronic resource]
260 _bClinical and experimental dermatology
_cNov 2005
300 _a713-4 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aCrohn Disease
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aGastrointestinal Agents
_xadverse effects
650 0 4 _aHumans
650 0 4 _aInfliximab
650 0 4 _aPsoriasis
_xchemically induced
700 1 _aPuig, L
700 1 _aDalmau, J
700 1 _aRicart, E
700 1 _aRoe, E
700 1 _aAlomar, A
773 0 _tClinical and experimental dermatology
_gvol. 30
_gno. 6
_gp. 713-4
856 4 0 _uhttps://doi.org/10.1111/j.1365-2230.2005.01882.x
_zAvailable from publisher's website
999 _c15827793
_d15827793